BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35737408)

  • 21. Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis.
    Luff SA; Kao CY; Papoutsakis ET
    PLoS One; 2018; 13(9):e0203991. PubMed ID: 30231080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.
    Xu-Monette ZY; Medeiros LJ; Li Y; Orlowski RZ; Andreeff M; Bueso-Ramos CE; Greiner TC; McDonnell TJ; Young KH
    Blood; 2012 Apr; 119(16):3668-83. PubMed ID: 22275381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis, Biology, and Targeting of
    Flynt E; Bisht K; Sridharan V; Ortiz M; Towfic F; Thakurta A
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection.
    Eicheler W; Zips D; Dörfler A; Grénman R; Baumann M
    J Histochem Cytochem; 2002 Feb; 50(2):197-204. PubMed ID: 11799138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.
    Pérot G; Chibon F; Montero A; Lagarde P; de Thé H; Terrier P; Guillou L; Ranchère D; Coindre JM; Aurias A
    Am J Pathol; 2010 Oct; 177(4):2080-90. PubMed ID: 20884963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
    Manoharan V; Karunanayake EH; Tennekoon KH; De Silva S; Imthikab AIA; De Silva K; Angunawela P; Vishwakula S; Lunec J
    BMC Cancer; 2020 Jan; 20(1):72. PubMed ID: 32000721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
    Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
    Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine model elucidates function of p53 isoform in carcinogenesis and reveals novel circTP53 RNA.
    Niu G; Hellmuth I; Flisikowska T; Pausch H; Rieblinger B; Carrapeiro A; Schade B; Böhm B; Kappe E; Fischer K; Klinger B; Steiger K; Burgkart R; Bourdon JC; Saur D; Kind A; Schnieke A; Flisikowski K
    Oncogene; 2021 Mar; 40(10):1896-1908. PubMed ID: 33603167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 haploinsufficiency and functional abnormalities in multiple myeloma.
    Teoh PJ; Chung TH; Sebastian S; Choo SN; Yan J; Ng SB; Fonseca R; Chng WJ
    Leukemia; 2014 Oct; 28(10):2066-74. PubMed ID: 24625551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status.
    Quintás-Cardama A; Hu C; Qutub A; Qiu YH; Zhang X; Post SM; Zhang N; Coombes K; Kornblau SM
    Leukemia; 2017 Jun; 31(6):1296-1305. PubMed ID: 27885271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.
    Chen H; Huang H; Zhao J; Wang Z; Chang M; Xue L; Zhu W; Chai Y; Li G; Wang Z; Wu H
    J Neurooncol; 2019 Jul; 143(3):369-379. PubMed ID: 31049827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer.
    De Souza C; Madden J; Koestler DC; Minn D; Montoya DJ; Minn K; Raetz AG; Zhu Z; Xiao WW; Tahmassebi N; Reddy H; Nelson N; Karnezis AN; Chien J
    J Natl Cancer Inst; 2021 Sep; 113(9):1246-1257. PubMed ID: 33555293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in p53 research: an interdisciplinary perspective.
    Olivier M; Petitjean A; Marcel V; Pétré A; Mounawar M; Plymoth A; de Fromentel CC; Hainaut P
    Cancer Gene Ther; 2009 Jan; 16(1):1-12. PubMed ID: 18802452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells.
    Nakazawa S; Sakata KI; Liang S; Yoshikawa K; Iizasa H; Tada M; Hamada JI; Kashiwazaki H; Kitagawa Y; Yamazaki Y
    Biomed Res; 2019; 40(1):37-49. PubMed ID: 30787262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the Long Noncoding RNA DINO in Human Papillomavirus-Positive Cervical Cancer Cells Reactivates the Dormant TP53 Tumor Suppressor through ATM/CHK2 Signaling.
    Sharma S; Munger K
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Long Non-Coding RNAs in Human-Induced Pluripotent Stem Cells Derived Megakaryocytes: A p53, HOX Antisense Intergenic RNA Myeloid 1, and miR-125b Interaction Study.
    Dahariya S; Raghuwanshi S; Thamodaran V; Velayudhan SR; Gutti RK
    J Pharmacol Exp Ther; 2023 Jan; 384(1):92-101. PubMed ID: 36243404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRIMA-1
    Jaskova Z; Pavlova S; Malcikova J; Brychtova Y; Trbusek M
    Leuk Res; 2020 Feb; 89():106288. PubMed ID: 31924585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour.
    Marin MC; Jost CA; Brooks LA; Irwin MS; O'Nions J; Tidy JA; James N; McGregor JM; Harwood CA; Yulug IG; Vousden KH; Allday MJ; Gusterson B; Ikawa S; Hinds PW; Crook T; Kaelin WG
    Nat Genet; 2000 May; 25(1):47-54. PubMed ID: 10802655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.
    Merkle FT; Ghosh S; Kamitaki N; Mitchell J; Avior Y; Mello C; Kashin S; Mekhoubad S; Ilic D; Charlton M; Saphier G; Handsaker RE; Genovese G; Bar S; Benvenisty N; McCarroll SA; Eggan K
    Nature; 2017 May; 545(7653):229-233. PubMed ID: 28445466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.